Use of imaging and biomarker tests for posttreatment care of early-stage breast cancer survivors

Cancer

Volumn 119, Issue 24, 2013, Pages 4316-4324

  Hahn, Erin E ^a,b   Hays, Ron D ^b,c   Kahn, Katherine L ^b,c   Litwin, Mark S ^b   Ganz, Patricia A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c RAND CORPORATION   (United States)

Author keywords

breast cancer; guideline adherence; health services; posttreatment care; surveillance

Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; CA 125 ANTIGEN; CA 15-3 ANTIGEN; CA 27-29 ANTIGEN; CARCINOEMBRYONIC ANTIGEN;

ADULT; AGE; AGED; ARTICLE; BONE SCINTISCANNING; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVOR; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE SURVEILLANCE; EARLY CANCER; ECHOGRAPHY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MASTECTOMY; MEDICAL RECORD REVIEW; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL MASTECTOMY; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTOCOL COMPLIANCE; THORAX RADIOGRAPHY; VERY ELDERLY;

BREAST CANCER; GUIDELINE ADHERENCE; HEALTH SERVICES; POSTTREATMENT CARE; SURVEILLANCE;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CONTINUITY OF PATIENT CARE; DIAGNOSTIC IMAGING; FEMALE; GUIDELINE ADHERENCE; HUMANS; MEDICAL RECORDS; MIDDLE AGED; POPULATION SURVEILLANCE; TUMOR MARKERS, BIOLOGICAL;

EID: 84889885069     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28363     Document Type: Article

References (30)

1. Siegel R, DeSantis C, Virgo K, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012; 62: 220-241.
2. American Cancer Society. Cancer Facts & Figures 2012. Atlanta, GA: American Cancer Society; 2012.
3. Rosselli Del Turco M, Palli D, Cariddi A, Ciatto S, Pacini P, Distante V,. Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial. National Research Council Project on Breast Cancer follow-up. JAMA. 1994; 271: 1593-1597.
4. Liberati A,. The GIVIO trial on the impact of follow-up care on survival and quality of life in breast cancer patients: Interdisciplinary Group for Cancer Care Evaluation. Ann Oncol. 1995; 6 (suppl 2): 41-46.
5. The GIVIO Investigators. Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial. JAMA. 1994; 271: 1587-1592.
6. Rojas MP, Telaro E, Russo A, et al. Follow-up strategies for women treated for early breast cancer. Cochrane Database Syst Rev. 2000;(4): CD001768.
7. Rojas MP, Telaro E, Russo A, et al. Follow-up strategies for women treated for early breast cancer (update). Cochrane Database Syst Rev. 2005;(1): CD001768.
8. American Society of Clinical Oncology. Recommended breast cancer surveillance guidelines. J Clin Oncol. 1997; 15: 2149-2156.
9. Smith TJ, Davidson NE, Schapira DV, et al. American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines. J Clin Oncol. 1999; 17: 1080-1082.
10. Khatcheressian JL, Wolff AC, Smith TJ, et al; American Society of Clinical Oncology. American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol. 2006; 24: 5091-5097.
11. Khatcheressian JL, Hurley P, Bantug E, et al; American Society of Clinical Oncology. Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013; 31: 961-965.
12. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines: breast cancer. http://www.nccn.org/professionals/physician-gls/f-guidelines. asp#breast. Accessed July 8, 2013.
13. Lafata J, Simpkins J, Schultz L, et al. Routine surveillance care after cancer treatment with curative intent. Med Care. 2005; 43: 592-599.
14. Keating N, Landrum M, Guadagnoli E, et al. Surveillance testing among survivors of early-stage breast cancer. J Clin Oncol. 2010; 25: 1074-1081.
15. Mandelblatt J, Lawrence W, Cullen J, et al. Patterns of care in early stage breast cancer survivors in the first year after cessation of active treatment. J Clin Oncol. 2006; 24: 77-84.
16. Grunfeld E, Hodgson D, Del Giudice M, et al. Population-based longitudinal study of follow-up care for breast cancer survivors. J Oncol Pract. 2010; 6: 174-181.
17. Dinan MA, Curtis LH, Hammill BG, et al. Changes in the use and costs of diagnostic imaging among Medicare beneficiaries with cancer, 1999-2006. JAMA. 2010; 303: 1625-1631.
18. Schnipper LE, Smith TJ, Raghavan D, et al. American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology. J Clin Oncol. 2012; 30: 1715-1724.
19. Good Stewardship Working Group. The "top 5" lists in primary care: meeting the responsibility of professionalism. Arch Intern Med. 2011; 171: 1385-1390.
20. Smith-Bindman R, Lipson J, Marcus R, et al. Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch Intern Med. 2009; 169: 2078-2086.
21. Brodersen J, Siersma VD,. Long-term psychosocial consequences of false-positive screening mammography. Ann Fam Med. 2013; 11: 106-115.
22. Cooper G, Johnson C, Lamerato L, et al. Use of guideline recommended follow-up care in cancer survivors: routine or diagnostic indications? Med Care. 2006; 44: 590-594.
23. Viera A, Garrett J,. Understanding interobserver agreement: the Kappa statistic. Fam Med. 2005; 37: 360-363.
24. Schapira MM, McAuliffe TL, Nattinger AB,. Underutilization of mammography in older breast cancer survivors. Med Care. 2000; 38: 281-289.
25. Sabatino SA, Thompson TD, Richardson LC, et al. Health insurance and other factors associated with mammography surveillance among breast cancer survivors: results from a national survey. Med Care. 2012; 50: 270-276.
26. Keating NL, Landrum MB, Guadagnoli E, Winer EP, Ayanian JZ,. Factors related to underuse of surveillance mammography among breast cancer survivors. J Clin Oncol. 2006; 24: 85-94.
27. Field TS, Doubeni C, Fox MP, et al. Under utilization of surveillance mammography among older breast cancer survivors. J Gen Intern Med. 2008; 23: 158-163.
28. Panageas K, Sima C, Liberman L, et al. Use of high technology imaging for surveillance of early stage breast cancer. Breast Cancer Res Treat. 2012; 131: 663-670.
29. Pivot X, Asmar L, Hortobagyi GN, Theriault R, Pastorini F, Buzdar A,. A retrospective study of first indicators of breast cancer recurrence. Oncology. 2000; 58: 185-190.
30. Keating N, Landrum M, Guadagnoli E, et al. Surveillance testing among survivors of early-stage breast cancer. J Clin Oncol. 2007; 25: 1074-1081.